ISRCTN77659599已完成未知
Insulin Lispro mixtures (mid mixture and low mixture) administered three times daily compared with human insulin 30/70 administered twice daily in insulin-requiring patients with type 2 diabetes
Department of Health (UK)0 个研究点目标入组 0 人开始时间: 2003年9月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Patients aged 35 years and over with type 2 diabetes and using insulin.
排除标准
- •Does not match inclusion criteria
研究者
相似试验
已完成
4 期
Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light BreakfastCTRI/2009/091/000609Eli Lilly300
进行中（未招募）
不适用
Comparison of Premixed Insulin Lispro Low Mixture and Mid Mixture Regimens with Separate Basal and Bolus Insulin Injections in Patients with Type 2 Diabetes with Inadequate Glycemic Control on Oral Therapy who Consume Light BreakfastEUCTR2007-005061-36-PTEli Lilly and Company Ltd.325
进行中（未招募）
1 期
Comparación de insulina lispro premezclada (proporción baja) dos veces al día frente a insulina glargina una vez al día e insulina lispro prandial una vez al día, como estrategias de intensificación de la insulinoterapia en pacientes con diabetes tipo 2 que presentan un control glucémico inadecuado con insulina glargina y metformina y/ó pioglitazona Comparison of Twice-Daily Insulin Lispro Low Mixture versus Once-Daily Basal Insulin Glargine and Once-Daily Prandial Insulin Lispro as Insulin Intensification Strategies in Patients with Type 2 Diabetes who have Inadequate Glycemic Control on Basal Insulin Glargine and Metformin and/or PioglitazoneEUCTR2010-019724-30-ESilly S.A.
已完成
不适用
Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariencEtype 2 diabetes using insulinJPRN-UMIN000001327Jikei University School of Medicine20
已完成
4 期
A Study for Type 2 Diabetic PatientsType 2 Diabetes MellitusNCT00548808Eli Lilly and Company426